Table 5.
(1) Ln Approval Time (Months) | (2) Approval Time | (3) Approval Time (Months) | |
---|---|---|---|
Panel A: Cardiovascular Subsample Only (by Prod. Code) | |||
| |||
First in Product Code | 0.2334* (0.1292) | 5.1143** (2.4862) | 6.8224** (2.6205) |
N | 183 | 183 | 163 |
R2 | 0.5009 | 0.4372 | 0.4118 |
| |||
Panel B: Devices in 8 Functional Categories | |||
| |||
First in Category | 0.1624 (0.2767) | 2.7185 (5.3434) | 9.0857 (5.8699) |
N | 183 | 183 | 179 |
R2 | 0.4899 | 0.4206 | 0.4218 |
| |||
Panel C: Controlling for Technological Uncertainty | |||
| |||
First in Product Code | 0.2327* (0.1376) | 5.2872** (2.6466) | 7.1890** (2.8121) |
First in Category | 0.0041 (0.2934) | −1.1056 (5.6446) | −2.1300 (5.7774) |
N | 183 | 183 | 163 |
R2 | 0.5009 | 0.4374 | 0.4125 |
p<0.05,
p<0.01,
p<0.001
This table looks at first entrants and their respective approval delays in a) product codes b) functional categories and c) both in the same model.
All models include firm and year fixed effects. Models also include controls for whether a product was granted “priority” (expedited) review and a count of the applicant firm’s approved applications at the time of submission.
Column 1 presents a log-linear model, while Column 2 translates the result into months. Column 3 restricts the sample to only the first entrant plus those subsequent entrants who submitted applications after the first entrant’s approval decision was finalized.